Integrative Herbal Medicine for Chemotherapy-Induced Peripheral Neuropathy and Hand-Foot Syndrome in Colorectal Cancer: A Systematic Review and Meta-Analysis

Yihong Liu, Brian H May, Anthony Lin Zhang, Xinfeng Guo, Chuanjian Lu, Charlie Changli Xue, Haibo Zhang, Yihong Liu, Brian H May, Anthony Lin Zhang, Xinfeng Guo, Chuanjian Lu, Charlie Changli Xue, Haibo Zhang

Abstract

Objectives: To assess the clinical evidence for integrative herbal medicine therapy in the management of chemotherapy-induced peripheral neuropathy (CIPN) and hand-foot syndrome (HFS) resulting from treatments for colorectal cancer (CRC).

Design: Randomized controlled trials (RCTs) were identified from major English and Chinese databases. Participants had been diagnosed with CRC by pathology and had received or were undergoing chemotherapy. Interventions included herbal medicines administered orally or topically. Controls were placebo, supportive care or conventional chemotherapy for CRC. Methods followed the Cochrane handbook. Meta-analyses were grouped by study design, outcome measure, severity, and chemotherapy. Random-effects models with 95% confidence intervals were used. Heterogeneity was assessed as I2.

Results: Sixty-three RCTs (4286 participants) were included. Five used a placebo in the control groups. Fifty-eight studies tested oral herbal medicine, and 5 tested topical herbal medicine. Data were available for CIPN (60 studies) and HFS (12 studies). Fifty-seven studies combined orally administered herbal medicine with chemotherapy compared with the same chemotherapy. For CIPN, 33 studies used World Health Organization (WHO) criteria, 7 used Levi's criteria, and 10 used the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE). These were analyzed separately. For grades III + IV CIPN, there was a significant reduction in the integrative groups for WHO (relative risk [RR] 0.42 [0.23, 0.77], I2 = 0%) and Levi's (RR 0.28 [0.11, 0.69], I2 = 0%) but not NCI-CTCAE (RR 0.65 [0.37, 1.13], I2 = 26.4%). Hand and foot baths showed no differences for Levi's grades III + IV CIPN but a significant reduction in all grades (RR 0.69 [0.50, 0.95], I2 = 68.8%). For HFS (all grades) there was a significant reduction in the integrative groups for WHO (RR 0.62 [0.41, 0.96], I2 = 22%) but not for NCI-CTCAE (RR 0.93 [0.55, 1.55], I2 = 75.7%). Sensitivity analyses explored sources of heterogeneity.

Conclusions: Integrative herbal therapy appeared to reduce CIPN and HFS in people receiving chemotherapy for CRC. However, the strength of the evidence was limited by lack of blinding in most studies, potential for bias, and relatively short study durations.

Keywords: Chinese herbal medicine; chemotherapy-induced peripheral neuropathy; colorectal cancer; hand and foot syndrome; herbal medicine; integrative medicine; meta-analysis; systematic review.

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Flow diagram of the search, screening, and inclusion process.

References

    1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359-E386.
    1. Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115-132.
    1. Zhu J, Tan Z, Hollis-Hansen K, et al. Epidemiological trends in colorectal cancer in China: an ecological study. Dig Dis Sci. 2017;62:235-243.
    1. Flatters SJL, Dougherty PM, Colvin LA. Clinical and preclinical perspectives on chemotherapy-induced peripheral neuropathy (CIPN): a narrative review. Br J Anaesth. 2017;119:737-749.
    1. Seretny M, Currie GL, Sena ES, et al. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain. 2014;155:2461-2470.
    1. Cioroiu C, Weimer LH. Update on chemotherapy-induced peripheral neuropathy. Curr Neurol Neurosci Rep. 2017;17:47.
    1. de Gramont A, Bosset JF, Milan C, et al. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study. J Clin Oncol. 1997;15:808-815.
    1. Cassidy J, Clarke S, Diaz-Rubio E, et al. Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer. J Clin Oncol. 2008;26:2006-2012.
    1. Nikolaou V, Syrigos K, Saif MW. Incidence and implications of chemotherapy related hand-foot syndrome. Expert Opin Drug Saf. 2016;15:1625-1633.
    1. Kwakman JJ, Punt CJ. Oral drugs in the treatment of metastatic colorectal cancer. Expert Opin Pharmacother. 2016;17:1351-1361.
    1. Avan A, Postma TJ, Ceresa C, et al. Platinum-induced neurotoxicity and preventive strategies: past, present, and future. Oncologist. 2015;20:411-432.
    1. Poupon L, Kerckhove N, Vein J, et al. Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives. Expert Opin Drug Saf. 2015;14:1269-1282.
    1. Brewer JR, Morrison G, Dolan ME, Fleming GF. Chemotherapy-induced peripheral neuropathy: current status and progress. Gynecol Oncol. 2016;140:176-183.
    1. Chen XF, Wang R, Yin YM, et al. The effect of monosialotetrahexosylganglioside (GM1) in prevention of oxaliplatin induced neurotoxicity: a retrospective study. Biomed Pharmacother. 2012;66:279-284.
    1. Zhu Y, Yang J, Jiao S, Ji T. Ganglioside-monosialic acid (GM1) prevents oxaliplatin-induced peripheral neurotoxicity in patients with gastrointestinal tumors. World J Surg Oncol. 2013;11:19.
    1. Scontre VA, Martins JC, de Melo Sette CV, et al. Curcuma longa (turmeric) for prevention of capecitabine-induced hand-foot syndrome: a pilot study. J Diet Suppl. 2018;15:606-612.
    1. Elyasi S, Shojaee FSR, Allahyari A, Karimi G. Topical silymarin administration for prevention of capecitabine-induced hand-foot syndrome: a randomized, double-blinded, placebo-controlled clinical trial. Phytother Res. 2017;31:1323-1329.
    1. Miller KK, Gorcey L, McLellan BN. Chemotherapy-induced hand-foot syndrome and nail changes: a review of clinical presentation, etiology, pathogenesis, and management. J Am Acad Dermatol. 2014;71:787-794.
    1. Wei XC, Zhu LQ, Wang H, et al. Efficacy of traditional Chinese medicines in preventing oxaliplatin-induced peripheral neurotoxicity in cancer patients: a network meta-analysis. Chin Herb Med. 2017;9:161-168.
    1. Hoshino N, Ganeko R, Hida K, Sakai Y. Goshajinkigan for reducing chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Int J Clin Oncol. 2018;23:434-442.
    1. Cascella M, Muzio MR. Potential application of the Kampo medicine goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy. J Integr Med. 2017;15:77-87.
    1. Kuriyama A, Endo K. Goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Supportive Care Cancer. 2018;26:1051-1059.
    1. Derksen TME, Bours MJL, Mols F, Weijenberg MP. Lifestyle-related factors in the self-management of hemotherapy-induced peripheral neuropathy in colorectal cancer: a systematic review. Evid Based Complement Alternat Med. 2017;2017:7916031. doi:10.1155/2017/7916031
    1. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration; 2011.
    1. Bao YJ, Qiu YY, Hu SJ, et al. The effect of Jianpibushen formula on postoperative adjuvant treatment of colorectal cancer [健脾补肾方对大肠癌术后辅助治疗的疗效]. Shanghai Med J. 2014;37:984-986.
    1. Cai ZB. Clinical Observation of Prevention of Oxaliplatin-Induced Neurotoxicity by Wenjinghuoxue Formula Bath [温经活血方外洗预防奥沙利铂周围神经毒性的临床观察]. Guangzhou, China: Guangzhou University of Chinese Medicine; 2016;12-16.
    1. Cao B. The clinical efficacy of Yiqijianpi decoction combined with FOLFOX4 in postoperative colorectal cancer patients [益气健脾汤联合FOLFOX4方案治疗结直肠癌术后患者的临床疗效]. Cancer Res Prev Treat. 2011;38:820-822.
    1. Chen CG. Clinical Trial of Jianpiyishen and Huayujiedu Therapy Combined With FOLFOX4 for Medium and Advanced Colorectal Cancer [健脾益肾,化瘀解毒法联合FOLFOX-4方案治疗中,晚期大肠癌的临床研究]. Nanjing, China: Nanjing University of Traditional Chinese Medicine; 2005;20-31.
    1. Chen XJ. Clinical Trial of Jianpihuashiquyu Formula Combined With Chemotherapy for Advanced Colorectal Cancer [健脾化湿祛瘀方联合化疗治疗晚期大肠癌的临床研究]. Nanjing, China: Nanjing University of Traditional Chinese Medicine; 2010:14-20.
    1. Chen Y. Experimental Study of the Influence of Weitiaosanhao Formula on Inflammatory Microenvironment of Colorectal Cancer and Clinical Trial of the Formula Plus SOX in Colorectal Cancer Patients [微调三号方对大肠癌炎性微环境影响的实验研究及其联合SOX方案的临床研究]. Nanjing: Nanjing University of Traditional Chinese Medicine; 2014:28-40.
    1. Cheng XL, Huo JG, Wang DW, et al. Herbal medicine AC591 prevents oxaliplatin-induced peripheral neuropathy in animal model and cancer patients. Front Pharmacol. 2017;8:344.
    1. Fang ZH, Li Y, Chen Y, Chen DL. Clinical observation of Jianpikangai formula combined with chemotherapy for advanced colorectal cancer [健脾抗癌方配合化疗治疗晚期大肠癌31例]. Shanghai J Tradit Chin Med. 2009;43:29-31.
    1. Feng YQ. Clinical observation of prevention and treatment of oxaliplatin-induced neurotoxicity by Chinese medicine hand and foot bath [中药外洗防治奥沙利铂神经毒性的护理观察]. Straits Pharm J. 2011;23:203-204.
    1. Gai L, Shi B, Zhang XB. The effect of Shenyi capsule plus XELOX versus XELOX for colorectal cancer [参一胶囊联合XELOX方案与单纯XELOX方案治疗晚期直肠癌的临床观察]. Mod J Integ Trad Chin West Med. 2010;19:1066-1067.
    1. Gao J, Yan SH, Li DP, et al. Clinical observation of Chinese medicine bath for prevention of oxaliplatin-induced neurotoxicity [中药泡洗预防奥沙利铂所致神经毒性的疗效观察]. Hebei J Trad Chin Med. 2015;37:994-996.
    1. Gao XM. Clinical Trial of Modified Bazhen Decoction on Decreasing the Adjuvant Chemotherapy Side Effects in Postoperative Colon Cancer Patients With Deficiency of Qi and Blood [八珍汤加减对结肠癌术后气血两虚型患者辅助化疗减毒作用的临床研究]. Fuzhou, China: Fujian University of Traditional Chinese Medicine; 2015:3-11.
    1. He JP, Qu JH. Clinical trial of Gubenjiedu therapy plus FOLFOX4 for advanced or recurrent rectal cancer [固本解毒法联合FOLFOX4方案化疗治疗晚期或复发性直肠癌的临床]. J Sichuan Trad Chin Med. 2013;31:76-78.
    1. He ZF. Clinical Trial of Yiqijianpi and Huayujiedu Formula Combined With FOLFOX for Postoperative Colorectal Cancer [益气健脾,化瘀解毒方合FOLFOX方案化疗治疗术后大肠癌的临床研究]]. Nanjing, China: Nanjing University of Traditional Chinese Medicine; 2006:8-17.
    1. Hou ZB. The Effect of Modified Banxiaxiexin Decoction for Postoperative Colorectal Cancer and Related Tumor Markers [半夏泻心汤加减对结直肠癌术后的临床疗效及相关血清肿瘤标志物的影响]. Guiyang, China: Guiyang College of Traditional Chinese Medicine; 2014:7-21.
    1. Hu B, Li G, An HM, et al. Clinical trial of Tenglong Buzhong decoction plus chemotherapy for advanced colorectal cancer [藤龙补中汤联合化疗治疗晚期大肠癌临床研究]. Chin Arch Trad Chin Med. 2015;33:37-39.
    1. Hu FS, Zhang Q, Wang XM, et al. Clinical trial of Gubenxiaoliu capsule plus FOLFOX4 for advanced colorectal cancer [固本消瘤胶囊联合FOLFOX4方案治疗晚期大肠癌的临床研究]. Chin J Inf Trad Chin Med. 2007;14:13-14.
    1. Hu QQ. Clinical trial of Chinese medicine three-step cytotherapy plus modified XELOX for stage IV colorectal cancer [中药三步周期疗法联合改良XELOX方案治疗Ⅳ期大肠癌的临床研究]. . Published 2013. Accessed Novenmber 21, 2018.
    1. Huang L, Guo JH. Clinical trial of Yiqihuatansanjie formula plus XELOX for advanced recurrent colon cancer [益气化痰散结方联合XELOX化疗方案治疗晚期复发性结肠癌的临床研究]. Chin Arch Trad Chin Med. 2014;32:670-672.
    1. Jiang ZM, Hu LQ, Jiang SS. Clinical observation of modified Sijunzi decoction plus FOLFOX6 for advanced colorectal cancer [加味四君子汤联合FOLFOX6方案治疗晚期结直肠癌临床观察]. Zhejiang Clin Med J. 2014;16:1296-1298.
    1. Jiao SJ, Fan CQ, An GY, et al. Clinical trial of Zibu decoction plus capecitabine as maintenance treatment in advanced colorectal cancer with deficiency of Qi and Blood after first-line chemotherapy [滋补汤联合卡培他滨维持治疗一线化疗后气血两虚证晚期结直肠癌的研究]. Mod J Int Trad Chin West Med. 2016;25:1258-1260,1317.
    1. Ke SW, Huang GD, Zhao J. Clinical trial of Kangaiyiliu formula plus CapeOx for advanced colorectal cancer [抗癌抑瘤方联合CapeOx方案治疗晚期结直肠癌]. Chin Trad Patent Med. 2015;37:49-54.
    1. Kono T, Hata T, Morita S, et al. Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double‑blind, placebo‑controlled trial of goshajinkigan to prevent oxaliplatin‑induced neuropathy. Cancer Chemother Pharmacol. 2013;72:1283-1290.
    1. Lai YQ, Chen NJ, Wu DH, Chen YY. Clinical observation of prevention of oxaliplatin-induced neurotoxicity by Jianpiyishen therapy in 27 cases [健脾益肾法预防奥沙利铂周围神经毒性27例. 福建中医药]. Fujian J Trad Chin Med. 2009;40:22-23.
    1. Li J. Clinical Observation and Mechanism Research of Fuzhenghuayujiedusanjie Method Plus Chemotherapy for Advanced Colorectal Cancer [扶正化瘀解毒散结配合化疗治疗晚期大肠癌的临床观察及机理研究]. Nanjing, China: Nanjing University of Traditional Chinese Medicine; 2011:12-24.
    1. Li L. Clinical trial of Jianpihuashiquyu Formula Plus Caplri for Advanced Colorectal Cancer [健脾化湿祛瘀方联合Caplri方案化疗治疗晚期大肠癌的临床研究]. Nanjing, China:Nanjing University of Traditional Chinese Medicine; 2007:11-20.
    1. Li LC. Clinical and experimental study of compound Changtai in treating colorectal cancer[复方肠泰治疗大肠癌的临床和实验研究]. . Accessed November 21, 2018.
    1. Li N. Clinical Trial of Jianpiyishen Therapy for Postoperative Colorectal Cancer [健脾益肾法治疗术后大肠癌的临床研究]. Nanjing, China: Nanjing University of Traditional Chinese Medicine; 2012;10-18.
    1. Li YJ, Chen JZ, Huang WX, Li XF. Clinical observation of Wenshenjianpi formula plus chemotherapy for elderly patients with advanced colorectal cancer [温肾健脾方联合化疗治疗老年进展期大肠癌的临床观察]. Fujian J Trad Chin Med. 2007;38:13-14.
    1. Liang XS, Chen MC, Chen DL, Lin Q. Clinical observation of prevention and treatment of oxaliplatin-induced neurotoxicity by Yiqilixueyufeng decoction in 46 cases [益气理血愈风汤防治奥沙利铂所致外周神经毒性反应46例]. Chin J Trad Med Sci Technol. 2012;19:94.
    1. Liang XS, Yan LL, Lin Q. Clinical observation of prevention and treatment of oxaliplatin-induced neurotoxicity by Lixuequfeng decoction [理血祛风汤防治大肠癌术后奥沙利铂所致外周神经毒性反应74例]. Zhejiang J Tradl Chin Med. 2015;50:522-523.
    1. Liu JP, Jiang J, Wei H, et al. Clinical observation of Huachansu capsule plus XELOX for advanced colon cancer [华蟾素联合XELOX方案治疗晚期结肠癌的临床疗效观察]. Med J West China. 2017;29:1560-1563.
    1. Liu P, Liu JH, Zhu DQ, et al. Clinical observation of Boerning capsule plus FOLFOX4 for colon cancer [博尔宁胶囊联合FOLFOX4方案治疗结肠癌的临床观察]. Chin J Clin Oncol. 2007;34:89-91.
    1. Liu SC. Clinical Observation of Yiqiyangying Method Plus FOLFOX6 for Medium and Advanced Colorectal Cancer [益气养阴中药配合FOLFOX6方案化疗治疗中晚期大肠癌的临床观察]. Beijing, China: Beijing University of Chinese Medicine; 2011:26-35.
    1. Liu YF, Zhu GY, Han L, Liu J, Ma T, Yu H. Clinical study on the prevention of oxaliplatin-induced neurotoxicity with Guilongtongluofang: results of a randomized, double-blind, placebo-controlled trial. Evid Based Complement Alternat Med. 2013;2013:541217.
    1. Ma J, Lu CW, Cai DF, Xu JM. Clinical observation of Jianpixiaoliu formula plus FOLFOX4 for advanced colon cancer [健脾消瘤方联合FOLFOX4方案治疗晚期结直肠癌临床观察]. J New Chin Med. 2015;47:208-210.
    1. Mao WD, Jiang LX, Zhou JY, Jiang HM. The effect of Chinese medicine plus chemotherapy to prevent the recurrence and metastasis of postoperative colorectal cancer [中药加化疗对大肠癌术后复发转移的影响研究]. Med J China. 2011;8:70-72.
    1. Mao ZJ, Zhu LM, Lu YL, Shen KP. The effect of Jianpi therapy plus FOLFOX on cancer-related fatigue, Th1/Th2 immune response balance and peripheral neuropathy in postoperative colon cancer patients [中医健脾法配合FOLFOX化疗方案对结肠癌术后患者癌因性疲乏, Th1/Th2免疫应答平衡及周围神经病变的影响]. Mod J Int Trad Chin West Med. 2017;26:4027-4030.
    1. Nishioka M, Shimada M, Kurita N, et al. The Kampo medicine, Goshajinkigan, prevents neuropathy in patients treated by FOLFOX regimen. Int J Clin Oncol. 2011;16:322-327.
    1. Oki E, Emi Y, Kojima H, et al. Preventive effect of Goshajinkigan on peripheral neurotoxicity of FOLFOX therapy (GENIUS trial): a placebo‑controlled, double‑blind, randomized phase III study. Int J Clin Oncol. 2015;20:767-775.
    1. Pan RR. Clinical Trial of Erlingyiren Decoction Plus XELOX in Postoperative Colorectal Cancer Patients With Spleen Deficiency, Dampness and Heat Syndrome [二苓苡仁汤联合XELOX方案化疗治疗肠癌术后脾虚湿热证的临床研究]. Nanjing, China: Nanjing University of Traditional Chinese Medicine; 2017:11-21.
    1. Pu QH. Experimental Study of the Effect of Weitiaosanhao Formula on VEGF, nm23-H1 and CK20 for Colorectal Cancer With Liver Metastasis and Clinical Trial of the Formula Plus FOLFOX4 in Colorectal Cancer With Liver Metastasis Patients [微调三号方对大肠癌肝转移VEGF, nm23-H1和CK20的影响的实验研研究及其联合FOLFOX4方案的临床研究]. Nanjing, China: Nanjing University of Traditional Chinese Medicine; 2012;31-41.
    1. Qin CY. Clinical Observation of Prevention and Treatment of Chemotherapy Side Effects by Jianpiyishen Therapy in Medium and Advanced Colorectal Cancer [健脾益肾治法防治中晚期结直肠癌化疗毒副反应的临床观察]. Beijing, China: Beijing University of Chinese Medicine; 2014;25-35.
    1. Shi RQ. Clinical Trial of Yiqijianpi Formula Plus XELOX for Postoperative Colorectal Cancer [益气健脾方联合XELOX方案治疗大肠癌术后患者的临床研究]. Nanjing, China: Nanjing University of Traditional Chinese Medicine; 2017;8-15.
    1. Shu JH, Zhou RY, Zhong Y, Wu LY. Clinical observation of Yiqijiedu decoction plus CapeOX for advanced colorectal cancer [益气解毒汤联合CapeOX方案治疗晚期大肠癌45例]. Shanghai J Trad Chin Med. 2011;45:33-35,45.
    1. Wang H. Clinical observation of Yiqihuoxuebuchang decoction plus chemotherapy for postoperative rectal cancer [益气活血补肠汤合化疗治疗直肠癌术后患者的疗效观察]. J Liaoning Univ Trad Chin Med. 2008;10:81-82.
    1. Wang JM. Clinical Observation of Jianpiyangyingqushijiedu Therapy Plus XELOX for Medium and Advanced Colorectal Cancer [健脾养阴祛湿解毒法联合XELOX方案治疗中晚期结直肠癌的临床疗效观察]. Nanjing, China: Nanjing University of Traditional Chinese Medicine; 2016;11-18.
    1. Wang JZ, Ke YH, Liu PC, et al. Clinical trial of Yichangning formula plus FOLFOX4 for advanced colorectal cancer in 30 cases [宜肠宁方联合FOLFOX-4方案治疗晚期结直肠癌30例临床研究]. Fujian J Trad Chin Med. 2011;42:23-24.
    1. Wang Q. Clinical observation of prevention and treatment of oxaliplatin-induced neurotoxicity by Huangqiguizhiwuwu decoction hand and foot bath plus calcium gluconate and magnesium sulphate [黄芪桂枝五物汤手足浴联合钙镁合剂防治奥沙利铂神经毒性的临床观察]. Mod J Integ Trad Chin West Med. 2015;24:318-320.
    1. Wang QY, He W, Lin Q, Li LR. Clinical observation of Chinese medicine plus chemotherapy for advanced colon cancer [中药联合化疗治疗晚期结肠癌的临床疗效观察]. Mod Digestion Intervent. 2015;20:387-389.
    1. Wang SW. Clinical Observation of Tongtai Decoction Plus XELOX for Advanced Colorectal Cancer [通泰合剂联合XELOX方案化疗治疗晚期大肠癌疗效临床观察]. Nanjing, China: Nanjing University of Traditional Chinese Medicine; 2012;14-23.
    1. Xie W. Clinical Observation on the Inhibitory Effect of Xiaoliu Decoction for Antiangiogenic VEGF in Colorectal Cancer [消瘤汤对结直肠癌VEGF抑制作用的临床研究]. Nanning, China: Guangxi University of Traditional Chinese Medicine; 2010;6-14.
    1. Xu C, Yu XW, Li M. Clinical observation of modified Xiangshaliujunzi decoction plus FOLFIRI for advanced colon cancer [加味香砂六君子汤联合FOLFIRI方案治疗晚期结肠癌]. Chin J Clin Med. 2012;19:36-37.
    1. Xu XQ, Qi YF. Clinical observation of Yiqihexue therapy for chemotherapy-induced neurotoxicity in colorectal cancer patients [益气和血法治疗大肠癌患者化疗所致神经毒性疗效分析]. World J Integ Trad West Med. 2014;9:1087-1089.
    1. Yang CD. Clinical observation on the effect of Chinese herbal fumigation on the peripheral neurotoxicity of oxaliplatin [中药熏洗治疗奥沙利铂所致周围神经毒性的临床观察]. China Clin Nurs. 2015;7:234-235.
    1. Ye HQ, Zhong MW, Chen XL, Tang RD. Clinical observation of Qifulongkui decoction plus chemotherapy for metastatic colorectal cancer in 30 cases [芪附龙葵汤联合化疗治疗转移性结直肠癌30例临床观察]. J Trad Chin Med. 2016;57:1490-1492,1496.
    1. Zeng JQ, Li ZP, Wang X. Clinical observation of Chinese medicine plus chemotherapy for advanced colorectal cancer in 30 cases [中医辨证施治配合化疗治疗晚期大肠癌30例]. J Jiangxi Univ Trad Chin Med. 2008;20:39-41.
    1. Zeng JY, He J, Wang QJ, et al. The effect of Xiaoliu decoction plus hyperthermic intraperitoneal chemotherapy on postoperative immune function and VEGF for advanced colorectal cancer [消瘤汤联合热灌注化疗对进展期结直肠癌术后免疫功能和血清血管内皮生长因子水平的影响]. J Guangxi Med Univ. 2010;27:415-416.
    1. Zhang C, Han ZG. Clinical observation of Chinese medicine plus chemotherapy for postoperative colorectal cancer [化疗联合中药治疗在结直肠癌术后的临床效果观察]. China Mod Med. 2015;22:135-138,141.
    1. Zhang Q, Wang XM, Yang GW, et al. Clinical trial of Gubenxiaoliu capsule plus FOLFOX4 for advanced colorectal cancer [固本消瘤胶囊联合FOLFOX4化疗方案治疗晚期大肠癌的临床研究]. Beijing J Trad Chin Med. 2010;29:255-257.
    1. Zhang WW, Chen J, Xie GQ, et al. Clinical trial of Jianpijiedu formula plus capecitabine for advanced colorectal cancer [健脾解毒方结合卡培他滨片治疗晚期大肠癌临床研究]. J Shanghai Univ Trad Chin Med. 2013;27:31-34.
    1. Zhong MW, Ye HQ, Li QZ, et al. The effect of Qifulongkui decoction plus chemotherapy on quality of life in the patient with metastatic colorectal cancer [芪附龙葵汤联合化疗对转移性结直肠癌患者生存质量的影响]. Mod J Integ Trad Chin West Med. 2016;25:1980-1982.
    1. Zhu FY, Wang B, Ai Y, et al. Clinical trial of Jianpiyiqijiedu formula plus chemotherapy for advanced colorectal cancer [健脾益气解毒方联合化疗治疗晚期大肠癌临床研究]. Mod J Integ Trad Chin West Med. 2016;25:261-263.
    1. Levi F, Misset JL, Brienza S, et al. A chronopharmacologic phase-II clinical-trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal-cancer. Cancer. 1992;69:893-900.
    1. Chen M, May BH, Zhou IW, Xue CC, Zhang Al. FOLFOX 4 combined with herbal medicine for advanced colorectal cancer: a systematic review. Phytother Res. 2014;28:976-991.
    1. Hosokawa A, Ogawa K, Ando T, et al. Preventive effect of traditional Japanese medicine on neurotoxicity of FOLFOX for metastatic colorectal cancer: a multicenter retrospective study. Anticancer Res. 2012;32:2545-2550.
    1. Kono T, Mamiya N, Chisato N, et al. Efficacy of Goshajinkigan for peripheral neurotoxicity of oxaliplatin in patients with advanced or recurrent colorectal cancer. Evid Based Complement Alternat Med. 2011;2011:418481.
    1. Yoshida N, Hosokawa T, Ishikawa T, et al. Efficacy of goshajinkigan for oxaliplatin-induced peripheral neuropathy in colorectal cancer patients. J Oncol. 2013;2013:139740.
    1. Kaku H, Kumagai S, Onoue H, et al. Objective evaluation of the alleviating effects of Goshajinkigan on peripheral neuropathy induced by paclitaxel/carboplatin therapy: a multicenter collaborative study. Exp Ther Med. 2012;3:60-65.
    1. Chen M, May BH, Zhou IW, et al. Meta-analysis of oxaliplatin-based chemotherapy combined with traditional medicines for colorectal cancer: contributions of specific plants to tumor response. Integr Cancer Ther. 2016;15:40-59.
    1. Chen M, May BH, Zhou IW, Sze DM, Xue CC, Zhang AL. Oxaliplatin-based chemotherapy combined with traditional medicines for neutropenia in colorectal cancer: a meta-analysis of the contributions of specific plants. Crit Rev Oncol Hematol. 2016;105:18-34.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa